Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong · Delayed Price · Currency is HKD 28.66
-0.10 (-0.35%)
Jun 26, 2026, 4:08 PM HKT
HKG:3692 Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, HKG:3692 stock has a consensus rating of "Strong Buy" and an average price target of $46.87. The average 1-year stock price forecast is 63.54% higher than the current stock price, while the lowest is $38.79 (+35.35%) and the highest is $52.84 (+84.37%).
Price Target: $46.87 (+63.54%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HKG:3692 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 21 | 19 | 18 | 18 | 16 | 16 |
| Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 27 | 25 | 25 | 25 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Guosheng Securities No rating | Guosheng Securities | Buy Maintains $40.61 | Buy | Maintains | $40.61 | +41.70% | Jun 19, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $48.80 | Buy | Maintains | $48.80 | +70.27% | May 26, 2026 |
| Bernstein | Bernstein | Buy Maintains $44.00 → $47.00 | Buy | Maintains | $44.00 → $47.00 | +63.99% | Apr 22, 2026 |
Unknown Analyst CSC Financial No rating | CSC Financial | Buy Maintains $48.73 | Buy | Maintains | $48.73 | +70.03% | Apr 20, 2026 |
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Maintains $45.00 | Buy | Maintains | $45.00 | +57.01% | Apr 20, 2026 |
Financial Forecast
Revenue This Year
16.93B
from 15.03B
Increased by 12.67%
Revenue Next Year
18.59B
from 16.93B
Increased by 9.79%
EPS This Year
0.99
from 0.93
Increased by 5.92%
EPS Next Year
1.09
from 0.99
Increased by 10.28%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.3B | ||
| Avg | 16.9B | ||
| Low | 16.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 15.2% | ||
| Avg | 12.7% | ||
| Low | 10.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.11 | ||
| Avg | 0.99 | ||
| Low | 0.90 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 18.8% | ||
| Avg | 5.9% | ||
| Low | -3.2% |